Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions
- PMID: 17718114
- DOI: 10.1159/000325787
Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions
Abstract
Objective: To examine whether p16(ink4a) immunocytochemical (ICC) expression detected intraepithelial disease in liquid-based cytology (LBC) specimens from women with high-grade squamous intraepithelial lesions (HSIL), whose specimen was labeled negative for intraepithelial lesion or malignany (NILM).
Study design: Residual LBC specimens from women treated for HSIL (n = 21), whose LBC test was interpreted as NILM including marked benign inflammatory changes (BCC) were used. The control (n = 25) consisted of residual LBC specimens from women with documented HSIL. ICC for p16p(16k4a) was performed on a second ThinPrep (ThinPrep 2000, Cylyl Corporation, Boxborough, Massachusetts, U.S.A.) preparation; the percentage ofpositive cells and intensity of immunostaining were recorded. Standard LBC preparations for p16(ink4a) ICC-positive and ICC-negative control cases were reviewed.
Results: Twenty-four of 25 (96%) of the HSIL control group were ICC p16(ink4a) positive. In the NILM/BCC group, 2 of 21 with adequate LBC residua were ICC p16(ink4a) positive; on review both were reclassified as epithelial abnormality--1 HSIL and 1 atypical squamous cells cannot exclude HSIL. In both, subsequent colposcopic biopsy yielded HSIL.
Conclusion: p16(ink4a) ICC positivity on NILM/BCC LBC residua from patients with HSIL may identify cases that merit cytologic review and possible reclassification. The utility of p16(ink4a) ICC in this situation requires further study.
Similar articles
-
P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.Acta Cytol. 2007 Sep-Oct;51(5):755-66. doi: 10.1159/000325839. Acta Cytol. 2007. PMID: 17910346
-
Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.Diagn Cytopathol. 2002 Dec;27(6):365-70. doi: 10.1002/dc.10205. Diagn Cytopathol. 2002. PMID: 12451568
-
Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.Coll Antropol. 2010 Mar;34(1):19-24. Coll Antropol. 2010. PMID: 20432728
-
[Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].Zhonghua Fu Chan Ke Za Zhi. 2020 Nov 25;55(11):784-790. doi: 10.3760/cma.j.cn112141-20200520-00428. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 33228350 Chinese.
-
Research advances in signaling pathways related to the malignant progression of HSIL to invasive cervical cancer: A review.Biomed Pharmacother. 2024 Nov;180:117483. doi: 10.1016/j.biopha.2024.117483. Epub 2024 Sep 30. Biomed Pharmacother. 2024. PMID: 39353319 Review.
Cited by
-
Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer.Virchows Arch. 2008 Dec;453(6):545-55. doi: 10.1007/s00428-008-0687-5. Epub 2008 Oct 21. Virchows Arch. 2008. PMID: 18936966
-
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.Cancer Treat Rev. 2009 May;35(3):210-20. doi: 10.1016/j.ctrv.2008.10.005. Epub 2009 Mar 3. Cancer Treat Rev. 2009. PMID: 19261387 Free PMC article.